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Abstract 
Hyposmolarity activates amino acid efflux as part of the corrective volume process in a variety of 
cells. This review discusses the mechanism of amino acid release in brain cells preparations. Results 
present evidence of substantial differences between the efflux of taurine and that of GABA and glu-
tamate, which besides a possible role as osmolytes, have a main function as synaptic transmitters. 
The differences found concern the efflux time course, the sensitivity to Cl– channel blockers, the mod-
ulation by tyrosine kinases, the influence of PKC and the effect of cytoskeleton disruptive agents. 
While taurine efflux features fit well with the mechanisms so far described in most cell types, the 
efflux of GABA and glutamate does not. Alternate mechanisms for the release of these two amino 
acids are discussed, including a PKC-modulated, actin-dependent exocytosis. 
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Introduction 
 
Most cells respond to decreases in external osmolarity by rapid swelling, followed by a 
corrective process leading to cell volume recovery, usually referred as regulatory volume 
decrease (RVD) (1). This is an active process accomplished by the extrusion of intracellular 
osmolytes, occurring essentially through leak pathways. The main intracellular ions K+ and 
Cl– are important osmolytes, but also a number of organic molecules, polyols, organic 
amines and particularly amino acids, are significantly involved in RVD (fig. 1). In fact, the 
contribution of organic osmolytes in brain during chronic hyponatremia, is crucial for 
maintaining the brain water content within limits compatible with survival (2) (fig. 1). 
 
 
 
Figure 1. Inorganic and organic osmolytes involved in the control of brain water content 
during chronic hyponatremia in mice. A: Relative contribution of the various osmolytes 
to cell volume correction. B: Decrease in the brain content of amino acids, creatine, and 
myo-inositol after 2–7 days of chronic hyponatremia in mice. Empty bar: normal brain 
content of osmolytes. Recalculated from (2). GPC: glycerophosphorylcholine, PEA: phos-
phatidyl ethanolamine, NAA: N-acetyl aspartate, Cr/PCr: creatine/phosphocreatine, 
Myo-I: myo-inositol, AA: amino acids. 
 
A simple approach to consider a molecule as potential osmolyte is to examine its re-
sponse to hyposmotic swelling. A large number of reports in the last years document the 
osmosensitive efflux of amino acids in many cell types, including brain cells and glial cells 
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as well as neurons (3–5). Amino acid release has been also observed in more integrated 
preparations such as brain slices (6–8), supraoptic nucleus (9), and in the brain in vivo us-
ing paradigms of microdialysis or superfusion (10,11). Amino acids released upon hy-
posmosis are preferentially taurine, GABA, glycine, and glutamate. N-acetyl aspartate also 
seems to be released by hyposmolarity, particularly from neurons (12). The increased ef-
flux of amino acids consistently observed in all these preparations has its counterpart in 
the decrease in tissue levels (10). In chronic hyponatremic mice, taurine concentrations are 
reduced to only 15% of its initial value, while glutamate levels are reduced to 60%. Studies 
about the mechanism of this release have been carried out preferentially on taurine because 
of its particular features such as metabolic inercy, high concentrations, and prompt release 
upon the hyposmotic stimulus (13). For these reasons, taurine has been considered as rep-
resentative of amino acid osmolytes, and it has been currently assumed that results ob-
tained for taurine are valid for other amino acids as well. In the present work, we present 
evidence about substantial differences between the mechanisms of hyposmolarity-acti-
vated release of taurine and those of GABA and glutamate, which not only suggest differ-
ences in the pathways but likely also in the functional meaning of this release. 
 
The Efflux Pathway 
 
Studies in cultured astrocytes and neurons document the efflux of taurine, GABA, gluta-
mate, and glycine in response to hyposmotic stimulus (3). Taurine efflux occurs through a 
leak pathway, with essentially no contribution of the energy-dependent carrier (4,5). The 
diffusive nature of the taurine permeation pathway is suggestive of a channel-like mole-
cule as the mechanism for efflux. Since osmosensitive taurine release in most cell types, 
including cultured astrocytes and neurons, is sensitive to Cl– channel blockers (14), an an-
ion channel-like molecule has been proposed as the common pathway for the corrective 
fluxes for Cl– and amino acid during RVD. In fact, it is known that the volume-activated 
Cl– channel exhibits a broad range of permeability, which includes all monovalent anions 
and even large molecules such as benzoate (15). Taurine, glutamate, and aspartate, all per-
meate through this channel when they are present in anionic form (15), suggesting that the 
size of the pore is large enough to allow the passage of these amino acids. Still, the question 
remains about how amino acids, which are found in the cell mostly as zwitterions, may 
translocate through an anion channel. 
It has been often assumed that other amino acids released by hyposmolarity permeate 
by a similar pathway as taurine, but this has not been studied in detail. In a study in hip-
pocampal slices directed to address to this question, we found remarkable differences be-
tween the efflux of taurine and the release of GABA and glutamate (16). The first main 
difference is the time course, as illustrated in figure 2A. While the efflux of taurine slowly 
activates and essentially does not inactivate, those of glutamate and GABA are character-
ized by rapid activation and inactivation. The sensitivity to Cl– channel blockers further 
reveals these differences. In most cell types, the osmosensitive efflux of taurine is markedly 
decreased by agents such as NPPB (5-Nitro-[3-phenylpropylamino]benzoic acid), DDF 
(dideoxyforskolin), niflumic acid, and DIDS (4,4′-diisothiocyanato-stilbene-2-2′ disulfonic 
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acid), which also effectively block the volume-activated Cl– channel (1,17). A report in cul-
tured astrocytes shows inhibition by DIDS of glutamate efflux but none of the other block-
ers was examined (18). The referred study in hippocampal slices revealed the insensitivity 
of the release of GABA and glutamate to NPPB and niflumic acid, which are potent block-
ers of taurine efflux also in this preparation (16) (fig. 2B). Only DIDS, at high concentra-
tions, was an efficient blocker of the efflux of GABA and glutamate. 
 
 
 
Figure 2. Time course and pharmacological profile of hyposmosis-induced amino acid 
efflux from rat hippocampal slices. A: Efflux time course. Slices were loaded with [3H]tau-
rine, [3H]GABA, and [3H]D-aspartate (as tracer for glutamate), washed and superfused 
with warmed isosmotic medium (1 ml/min) and after reaching stable basal efflux (arrow), 
superfusion continued with 30% hyposmotic medium, made by reducing NaCl. B: Effect 
of Cl– channel blockers. Slices were preincubated 15 min in isosmotic medium with 100 
mM NPPB, 100 μm niflumic acid or 600 μM DIDS. Blockers were present in all superfu-
sion solutions. Bars represent the amino acid released during 20 min of exposure to hy-
posmotic medium minus the release in isosmotic medium during the same time period. 
Data are arranged from Franco et al. (16). 
 
Release of taurine, glutamate, and GABA in response to hyposmolarity has also been 
observed in vivo using microdialysis or superfusion of the cortex surface (10,11). Here 
again, the release of aspartate and glutamate was insensitive to Cl– channel blockers (11). 
All together, these findings showing major differences in the mechanism of amino acid 
release are suggestive of different pathways, which in the case of GABA and glutamate 
would also considerably differ from the volume-sensitive Cl– channel. 
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Transduction Signaling 
 
Volume regulation is a complex process which initiates by detection of the change in cell 
volume, followed by the trigger of signaling cascades, ultimately leading to activation of 
effectors, i.e., the various translocation pathways in charge of the osmolyte extrusion nec-
essary for volume correction. At a certain point, the cell should “remember” its initial value 
and inactivate the efflux pathways. 
Most work about the mechanisms of RVD has focused on the characterization of the 
osmolyte efflux pathways, and it is only recently that other aspects of the volume adjust-
ment process have been examined. As the above mentioned, the first signal in the chain is 
necessarily the detection of the change in cell volume, and nevertheless, this volume sensor 
mechanism is essentially unknown in all cell types. As for the transduction signaling, some 
recent evidence relates second messengers such as Ca2+, such protein phosphorylation and 
phospholipases as elements of the transduction cascade (19–22). Here again, marked dif-
ferences have been found between a typical organic osmolyte such as taurine, and amino 
acids such as GABA and glutamate. 
 
Calcium 
A change in cytosolic calcium (Ca2+i) could be a key transduction messenger, since with 
few exceptions, hyposmotic swelling always results in an increase in Ca2+i levels (20). In 
spite of this general response, RVD and osmolyte fluxes are either Ca2+-dependent or Ca2+-
independent in the different cell types. Activation of the volume-sensitive Cl– channel is 
essentially Ca2+-independent in most cells. (rev. in 20). Similarly, taurine efflux is insensi-
tive to changes in Ca2+i in most cell types, including cultured neurons and astrocytes 
(23,24). Taurine release from brain slices is also essentially Ca2+-independent (16). The in-
fluence of Ca2+ on the efflux of glutamate and GABA has not been examined in detail. In 
hippocampal slices, it seems independent of external and internal Ca2+, although cytosolic 
Ca2+ cannot be fully depleted (16). In contrast to taurine and Cl– fluxes, the volume-activated 
K+ fluxes are Ca2+-dependent in numerous cell types but not in many others (20). It is wor-
thy to note that most cells showing these Ca2+ requirement for swelling-activated K+ chan-
nels, are epithelial cells and that the Ca2+-activated BK-type channels appear those involved 
in K+ permeation during swelling. Obviously, in these cells, RVD is also Ca2+-dependent, 
while it is not in cells where all the permeation pathways activated by swelling do not 
require Ca2+ (19). 
 
Protein Phosphorylation 
Recent evidence points to a key role of protein kinases as part of the signaling cascades to 
activate osmolyte fluxes (22,25). Tyrosine kinases appear involved in the mechanisms of 
osmosensitive release of Cl– and taurine, as shown by the inhibitory effect of tyrosine ki-
nase blockers such as tyrphostins, genistein, herbymicin, and lavendustin (19,26,27). Ac-
cordingly, blockers of tyrosine phosphatases, such as ortho-vanadate, which prolong the 
tryosine phosphorylation reactions, lead to marked potentiation of taurine and Cl– fluxes 
in various cell types, including cultured neurons and astrocytes (19,28). These results fur-
ther emphasize the close similarities between Cl– and taurine translocation pathways. The 
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specific tyrosine kinases involved in osmolyte fluxes are not well identified. This is further 
complicated by the known activation of a number of tyrosine kinases by hyposmolarity 
and swelling, which however, appear unrelated to the operation of the osmolyte efflux 
pathways. This is the case of the MAP kinases ERK1/ERK2 and p38, which are indeed ac-
tivated during swelling and RVD but have no influence on taurine and Cl– release in vari-
ous cell types, including neurons (28,29), and in hippocampal slices (fig. 3) (16). (An 
exception are cortical astrocytes in which ERK1/ERK2 appear connected with the volume-
activated Cl– channel) (30). This is not unexpected, since the hyposmotic shock and the 
subsequent swelling are complex phenomena, involving numerous processes such as cell 
adhesion and retraction, as well as dramatic changes in the cytoskeleton organization. All 
these adaptations represent also stressful situations for the cell and some of these kinases 
are stress-activated enzymes. Therefore, it is necessary to discriminate among the plethora 
of signals activated by hyposmosis and swelling, those being strictly connected with the 
activation of corrective osmolyte pathways leading to RVD. 
 
 
 
Figure 3. Activation of ERK1/2 by hyposmosis in cerebellar granule neurons and in hip-
pocampal slices, and lack of connection of this activity with the osmosensitive taurine 
efflux. Cultured cerebellar granule neurons (A) or hippocampal slices (B) were exposed 
to media: isosmotic (Iso), 30% hyposmotic (Hyp), or 30% hyposmotic + 50 μM PD98058 
(Hyp + PD). Upper panel: ERK1/ERK2 activity in the different conditions. ERK1/ERK2 
assay was performed as described in Morales-Mulia et al. (26). Briefly, aliquots of the cell 
lysate were immunoprecipitated with a polyclonal antibody to ERK1/ERK2. Immune 
complexes were collected by protein A sepharose and incubated with myelin basic protein 
(MBP) as substrate and [32P]ATP. The activity of ERK1/ERK2 was monitored via autora-
diography after SDS/PAGE electrophoresis. Lower panel: Lack of effect of the ERK1/2 ac-
tivation blocker PD98058 on the hyposmolarity-induced release of taurine, despite the 
reduction in ERK activity. A. reproduced from Morales-Mulia et al. (26) and B. from Fran-
co et al. (16). 
PA S A N T E S -M O R A L E S  E T  A L . ,  N E U R O C H E M I C A L  R E S E A R C H  2 7  (2 0 02 )  
7 
Studies so far have identified the tyrosine-kinase activated kinase P13K, as one directly 
related to taurine efflux during RVD. P13K is activated by hyposmolarity, and this reaction 
is blocked by wortmannin and LY294002 (16,28,31). These agents, particularly wortman-
nin, markedly inhibit taurine (and Cl–) fluxes (16,28,31). The magnitude and the time 
course of taurine efflux reduction by P13K blockers are rather similar to those due to gen-
eral blockers of tyrosine kinases, suggesting this enzyme as a main target of tyrosine kinase 
activity. A noteworthy effect of the Cl– channel and tyrosine kinase blockers observed in 
hippocampal slices is the persistence of a small peak of taurine, evident only when the 
blockers have blunted most of the efflux. This component, which accounts for about 17%, 
shows rapid activation and inactivation and seems similar in all respects, to the D-aspar-
tate efflux (fig. 4). 
 
 
 
Figure 4. Effects of tyrosine kinase blockers on hyposmolarity-elicited release of taurine, 
GABA, and D-aspartate. Loading and superfusion of slices as in figure 2. Tyrphostine 
AG18 (50 μM), a blocker of tyrosine kinases, markedly reduced [3H]taurine release with-
out significantly affecting the efflux of [3H]GABA and [3H]D-aspartate. The same different 
effects are observed in the presence of wortmannin (100 nM), a blocker of the tyrosine 
kinase-activated kinase P13K. Both blockers revealed a resistant component of taurine ef-
flux which, similar to those of GABA and glutamate, appears not modulated by tyrosine 
kinases. Data arranged from Franco et al. (16). 
 
In contrast to these important influences of tyrosine and tyrosine-activated kinases on 
taurine fluxes, D-aspartate efflux is resistant to these agents, as reported in cultured astro-
cytes and hippocampal slices (16,32) (fig. 4). This remarkable difference is a clear indication 
of different signaling pathways for trigger of taurine and glutamate release. Being gluta-
mate a neurotransmitter, its release may respond to other stimuli associated with events 
concurrent with swelling or/and volume regulation, such as swelling-associated depolari-
zation, known to occur in various cell types, including astrocytes. However, this response 
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is likely due to rapid Cl– extrusion through the volume-activated pathway, and should be 
consequently prevented by niflumic acid or NPPB. Thus, the insensitivity of GABA/gluta-
mate release to these blockers is against the notion of depolarization as the trigger for glu-
tamate release. The Na+ and Cl– independence of GABA and glutamate release as well as 
the insensitivity of this efflux to carrier blockers observed in hippocampal slices (16) seem 
to exclude the reverse operation of the energy-dependent transporter. The efflux is also 
independent of external Ca2+, and insensitive to internal Ca2+ stores depletion, thus making 
unlikely the involvement of the typically Ca2+-dependent vesicular release. However, this 
possibility cannot be definitely ruled out in the light of some recent evidence next dis-
cussed. 
 
Calcium-Independent Exocytosis? 
 
The hyposmotic stimulus trigger active phenomena of exocytosis in various cell types, 
which are either Ca2+-dependent or -independent (33). This raises the possibility of exocy-
tosis as the mechanism of GABA and glutamate release associated with swelling, although 
the vesicular release of these amino acids is typically Ca2+-dependent. However, recent ev-
idence points to occurrence of exocytotic release without a previous Ca2+ signal (34,35). The 
focus of this argument is that the submembrane actin filaments are organized as a mesh 
preventing exocytosis of the pool of synaptic vesicles trapped in this network. The disas-
sembly dynamics occurs via Ca2+ and associated proteins and seems modulated by PKC, 
likely via an effect increasing vesicular release sensitivity to Ca2+. Thus it can be speculated 
whether hyposmolarity in association with PKC could activate exocytosis at basal Ca2+ lev-
els, or even at residual Ca2+ levels in Ca2+-depleted preparations. In support of this hypoth-
esis are results in hippocampal slices (16) showing that the osmosensitive release of 
glutamate is modulated by PKC (reduced by the blocker chelerythrine and enhanced by 
phorbol-12-myristate-13 acetate) and potentiated by the cytoskeleton disruption elicited 
by cytochalasin E. Noteworthy, these maneuvers do not affect taurine release, further em-
phasizing the differences in the mechanisms for release between these two amino acids. 
These findings, although intriguing, have to be considered as preliminary, since they 
have so far been observed in only a few preparations. Such kind of studies should be ex-
tended to other brain preparations, including neurons of various types and different brain 
regions, and more importantly, to nonnervous cell types. It is not unlikely that in cells 
where these amino acids do not play a role as synaptic transmitters, their response to hy-
posmotic swelling is restricted to an osmolyte type and the mechanisms of release is in all 
alike to that of taurine. 
In any event, the observations here presented explain a number of effects of osmolarity 
described in hippocampal slices, such as the reversible hyposmolarity-dependent enhance-
ment of excitatory postsynaptic potentials, and to a lesser extent, also the inhibitory 
postsynaptic currents (36). This response of brain tissue to hyposmolarity, likely mediated 
by the mechanisms here described, may also explain the increased seizure susceptibility 
observed during hyponatremia (37). 
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